Global AI in Preventive Care Market Size to Grow At 48% CAGR From 2024 to 2030.

Global AI in Preventive Care Market Size (2024-2030)

As per our research report, AI in Preventive Care Market size is estimated to be growing at a CAGR of 48% from 2024 to 2030.

Artificial intelligence has exploded onto the scene in healthcare, drastically impacting patient care at every stage. The past decade has witnessed remarkable growth and transformation in the industry, fueled by AI integration. From chronic disease management to cancer diagnosis, radiology, and risk assessment, AI empowers healthcare providers with cutting-edge technology for improved efficiency and patient outcomes. Compared to traditional methods, AI boasts significant advantages in healthcare data analysis and decision making. Machine learning, cloud computing, and deep learning algorithms empower practitioners to extract valuable insights from complex data, leading to reduced treatment variations and improved clinical outcomes. AI's ability to replicate human cognition in interpreting and analyzing data has revolutionized healthcare. Essentially, algorithms make critical decisions without human intervention.

The booming use of AI and ML solutions in healthcare has fueled significant growth in the market. AI has emerged as a cornerstone of global health crisis management, streamlining disease detection, drug research, and robotic delivery during critical times. The COVID-19 pandemic served as a powerful showcase of AI's capabilities and expertise in healthcare. During the peak of the pandemic, medical facilities worldwide leveraged AI-powered automated systems, inpatient care bots, and AI-assisted surgical robots to manage the surge of patients that threatened to overwhelm their operations. This efficient response underscores the tremendous potential of AI to revolutionize healthcare and enhance patient outcomes.

The landscape of venture capital investments in the field of AI healthcare is experiencing a remarkable surge, catalyzing accelerated development and innovation within the industry. Notably, Navina, a pioneering startup specializing in the creation of an AI-driven platform for primary care, successfully raised an impressive USD 15 Million in a series A funding round in October 2021. This substantial investment infusion reflects a growing confidence among investors in the potential of AI technologies to revolutionize healthcare services. Navina's focus on leveraging artificial intelligence for primary care signifies a strategic alignment with the broader industry trend toward more intelligent and efficient healthcare solutions. The funds secured through the series A round are expected to play a pivotal role in furthering Navina's research, development, and deployment efforts

In the realm of artificial intelligence (AI) applications, market dynamics are experiencing a notable evolution. Currently dominated by industry titans such as IBM, Google, and Microsoft, the landscape is undergoing a shift as startups rapidly gain momentum. This changing market share scenario is not uniform across all sectors, with distinctive growth patterns observed in specific segments. Notably, the AI-powered diagnostics sector stands out, projecting an impressive Compound Annual Growth Rate (CAGR) of 52.4%. This surge in the diagnostics segment reflects a broader trend of increased investment and focus on AI applications in medical fields. While established players continue to wield influence, the agility and niche specialization of startups enable them to capture significant shares, particularly in burgeoning sectors, showcasing the industry's responsiveness to innovation and the pursuit of advanced, specialized AI solutions.

KEY MARKET INSIGHTS: 

• Within the burgeoning domain of AI in preventive care, distinguished players spearhead transformative contributions, each wielding substantial market influence. Foremost among these entities is IBM, securing an impressive 22% market share, corresponding to a valuation of $1.54 billion. Renowned for its multifaceted AI suite, IBM, notably through Watson Health, empowers healthcare providers with sophisticated tools for data analysis, facilitating nuanced risk assessments and identification of patients predisposed to specific maladies. This commanding market presence underscores IBM's pivotal role in shaping the trajectory of AI applications within the preventive care paradigm.

• Following closely is Google, commanding an 18% market share and a valuation of $1.26 billion. Google's indelible imprint on the AI preventive care landscape is discernible through its dedicated focus on early disease detection. Pioneering AI tools such as Google DeepMind's algorithm for discerning diabetic retinopathy from ocular scans exemplify the company's commitment to advancing diagnostic frontiers. This dual dominance by IBM and Google within the market epitomizes a dynamic synergy between comprehensive AI suites and specialized diagnostic innovations, heralding a future where AI plays an instrumental role in proactive healthcare solutions.

• Microsoft's introduction of the AI for Health program in January 2020, a groundbreaking initiative with a five-year, $40 million commitment, represents a significant stride in the application of artificial intelligence and machine learning (AI/ML) within the healthcare sector. This initiative stands as a driving force behind the accelerated adoption of AI/ML in healthcare, offering resources, grants, and technical expertise to foster collaboration among healthcare providers, researchers, and technology companies. The ultimate goal is to catalyze the development and deployment of innovative AI-powered solutions across various healthcare domains, promising to redefine patient care and contribute to improved community health outcomes.

• North America commands a substantial presence in the AI in preventive care market, representing an estimated 54.2% of the global market share in 2023. This dominance is propelled by the region's advanced healthcare infrastructure, substantial healthcare expenditures, and a favorable regulatory landscape. In parallel, the Asia Pacific region is set to experience unparalleled growth with a projected CAGR of 47.6% during the forecast period. This remarkable expansion is fueled by the region's burgeoning healthcare sector, heightened investments in AI technology, and a large and expanding population. Together, these trends underscore North America's entrenched leadership while spotlighting the Asia Pacific as an emerging powerhouse propelling the global trajectory of AI in preventive care.

AI In Preventive Care Market Segmentation:

By Offering

• Hardware
• Software
• Services

By Technology

• Machine Learning
• Natural Language Processing
• Context-aware Computing
• Computer Vision

By Application

• Medical Administration and Support
• Patient Management
• Research & Development
• Others

By End-User

• Pharmaceutical Companies
• Hospitals
• Patients
• Others

Regional Analysis

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Request sample for this report : https://virtuemarketresearch.com/report/ai-preventive-care-market/request-sample